EDHF-type relaxations evoked by CPA and ACh can also be potentiated by the sulphydryl reagent thimerosal, which amplifies Ca2+ release from the ER by oxidizing critical thiol groups present in the InsP3 receptor, thus raising the possibility of a molecular target common to H2O2 and thimerosal.
The molecular target of common insecticides such as pyrethroids and dichlorodiphenyltrichloroethane (DTT) is VGSC [ 24, 29].
Data sets available for curation include lists of posttranslational modifications, biological activities, sequence features (e.g., signal and propeptide sequences), the molecular target ontology, common names and images of spiders, and even the units used to describe LD50, PD50, and IC50 values.
But this week's FDA approval goes further: It makes clear that the drug's molecular targets are also common in colorectal, endometrial and gastrointestinal cancers, and less frequently present in cancers of the breast, prostate, bladder, and thyroid gland.
Together, these examples demonstrate how careful application and thorough analysis of expression microarrays can facilitate the discovery of novel molecular targets for intervening in common lung diseases.
The most common molecular targets of conotoxins are voltage- and ligand-gated ion channels, G protein-coupled receptors, and neurotransmitter transporters, to which they bind, typically, with high affinity and specificity.
Indeed, cholesterol and androgenic hormones (testosterone and androstenedione) are among the common molecular targets of these 6 genes, which are also implicated in a number of dysfunctional processes (embryonic development, neurogenesis, apoptosis, cytokine production) and disorders (inflammation, digestive disorder, muscle disorder) associated with ASD (Figure 4).
Interestingly, the same trend was observed for these genes in CnB1 and NFAT2-silenced cells, suggesting common molecular targets between Cn, NFAT1 and NFAT2 (supplementary Figure 4).
The discovery of common molecular targets for joint resident and inflammatory cells may help to develop the most effective therapeutic strategy.
Molecular assays targeting the IS711 insertion element and the bcsp31 gene, coding for a 31-kDa immunogenic outer membrane protein conserved among all Brucella spp. are the most common molecular targets in clinical applications (12, 13).
